155 related articles for article (PubMed ID: 12647444)
21. [Monitoring of serum olanzapine during antipsychotic treatment].
Linnet K; Olesen OV
Ugeskr Laeger; 2000 Sep; 162(36):4802-5. PubMed ID: 10994377
[TBL] [Abstract][Full Text] [Related]
22. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.
Martín JC; Palenciano G; Pérez R
J Clin Psychiatry; 2000 Dec; 61(12):948. PubMed ID: 11206602
[No Abstract] [Full Text] [Related]
24. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
25. Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan.
Liu CY; Chiu NY; Wu CK; Yuan LM; Hsiao MC; Liao O
Int Clin Psychopharmacol; 2003 Jan; 18(1):49-51. PubMed ID: 12490775
[TBL] [Abstract][Full Text] [Related]
26. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
[TBL] [Abstract][Full Text] [Related]
27. High-dose olanzapine for treatment-refractory schizophrenia.
Sheitman BB; Lindgren JC; Early J; Sved M
Am J Psychiatry; 1997 Nov; 154(11):1626. PubMed ID: 9356581
[No Abstract] [Full Text] [Related]
28. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.
Ho BC; Miller D; Nopoulos P; Andreasen NC
J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of antipsychotic drugs.
Messori A
Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
[No Abstract] [Full Text] [Related]
30. Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
Kasper S; Hale A; Azorin JM; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 2():II1-II14. PubMed ID: 10603070
[No Abstract] [Full Text] [Related]
31. Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia.
Chue P; Jones B; Taylor CC; Dickson R
Can J Psychiatry; 2002 Oct; 47(8):771-4. PubMed ID: 12420656
[TBL] [Abstract][Full Text] [Related]
32. Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients.
Barak Y; Shamir E; Zemishlani H; Mirecki I; Toren P; Weizman R
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1199-202. PubMed ID: 12452546
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
Jones B; Taylor CC; Meehan K
J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
[TBL] [Abstract][Full Text] [Related]
34. Comparable dopamine 2 receptor occupancy.
de Haan L; van Amelsvoort T
Am J Psychiatry; 2002 Dec; 159(12):2118; author reply 2118-9. PubMed ID: 12450982
[No Abstract] [Full Text] [Related]
35. A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
Martin S; Lĵo H; Peuskens J; Thirumalai S; Giudicelli A; Fleurot O; Rein W;
Curr Med Res Opin; 2002; 18(6):355-62. PubMed ID: 12442883
[TBL] [Abstract][Full Text] [Related]
36. Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific.
Lee CT; Conde BJ; Mazlan M; Visanuyothin T; Wang A; Wong MM; Walker DJ; Roychowdhury SM; Wang H; Tran PV
J Clin Psychiatry; 2002 Jul; 63(7):569-76. PubMed ID: 12143912
[TBL] [Abstract][Full Text] [Related]
37. Clozapine to olanzapine.
Millson RC; Delva NJ
Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
[No Abstract] [Full Text] [Related]
38. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
39. Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.
Bronson BD; Lindenmayer JP
J Clin Psychopharmacol; 2000 Jun; 20(3):382-4. PubMed ID: 10831029
[No Abstract] [Full Text] [Related]
40. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
